Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Over Age 60 Treated with R-CHOP but not CHOP: A prospective ECOG and SWOG correlative study of E4494

PURPOSE: To prospectively investigate the prognostic significance of p21 and p53 expression in diffuse large B cell lymphoma (DLBCL) in the context of the US Intergroup trial comparing conventional cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy to rituximab (R)-CHOP i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Winter, Jane N., Li, Shuli, Aurora, Vikas, Variakojis, Daina, Nelson, Beverly, Krajewska, Maryla, Zhang, Lijun, Habermann, Thomas M., Fisher, Richard I., Macon, William R., Chhanabhai, Mukesh, Felgar, Raymond E., Hsi, Eric D., Medeiros, L. Jeffrey, Weick, James K., Weller, Edie A., Melnick, Ari, Reed, John C., Horning, Sandra J., Gascoyne, Randy D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2865202/
https://ncbi.nlm.nih.gov/pubmed/20371683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1219
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky